المؤلفون: Miller, DSJ, Schmierer, B, Hill, CS

المصدر: Journal of cell science. 132(14)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:141535824

المؤلفون: Vizan, P, Miller, DSJ, Gori, I, Das, D, Schmierer, B, Hill, CS

المصدر: Science signaling. 6(305)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:127924528

المؤلفون: Miller, Dsj

المصدر: Encyclopedia of Cell Biology: Functional Cell Biology. 2016, p37-50.

المؤلفون: Vizan, P, Miller, DSJ, Schmierer, B, Hill, CS

المصدر: Science signaling. 7(344)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:129938937

المؤلفون: Thomas KL; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K., Bouguenina H; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K., Miller DSJ; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K., Sialana FJ; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, U.K., Hayhow TG; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, U.K., Choudhary JS; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, U.K., Rossanese OW; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K., Bellenie BR; Centre for Cancer Drug Discovery, The Institute of Cancer Research, London SM2 5NG, U.K.

المصدر: ACS chemical biology [ACS Chem Biol] 2024 Jan 19; Vol. 19 (1), pp. 173-184. Date of Electronic Publication: 2024 Jan 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE

مواضيع طبية MeSH: Cyclins*/metabolism, Proteolysis ; Cell Cycle Checkpoints

المؤلفون: Harnden AC, Davis OA, Box GM, Hayes A, Johnson LD, Henley AT, de Haven Brandon AK, Valenti M, Cheung KJ, Brennan A, Huckvale R, Pierrat OA, Talbot R, Bright MD, Akpinar HA, Miller DSJ, Tarantino D, Gowan S, de Klerk S, McAndrew PC, Le Bihan YV, Meniconi M, Burke R, Kirkin V, van Montfort RLM, Raynaud FI, Rossanese OW, Bellenie BR, Hoelder S

المصدر: Journal of medicinal chemistry [J Med Chem] 2023 Apr 27; Vol. 66 (8), pp. 5892-5906. Date of Electronic Publication: 2023 Apr 07.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/pathology , Quinolones*, Animals ; Humans ; Mice ; Cell Line, Tumor ; Disease Models, Animal ; Proto-Oncogene Proteins c-bcl-6/chemistry ; Transcription Factors

المؤلفون: Huckvale R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Harnden AC; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Cheung KJ; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Pierrat OA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Talbot R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Box GM; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Henley AT; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., de Haven Brandon AK; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Hallsworth AE; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Bright MD; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Akpinar HA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Miller DSJ; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Tarantino D; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Gowan S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Hayes A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Gunnell EA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.; Division of Structural Biology, The Institute of Cancer Research, London SM2 5NG, U.K., Brennan A; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Davis OA; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Johnson LD; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., de Klerk S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., McAndrew C; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Le Bihan YV; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.; Division of Structural Biology, The Institute of Cancer Research, London SM2 5NG, U.K., Meniconi M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Burke R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Kirkin V; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., van Montfort RLM; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.; Division of Structural Biology, The Institute of Cancer Research, London SM2 5NG, U.K., Raynaud FI; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Rossanese OW; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Bellenie BR; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K., Hoelder S; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, U.K.

المصدر: Journal of medicinal chemistry [J Med Chem] 2022 Jun 23; Vol. 65 (12), pp. 8191-8207. Date of Electronic Publication: 2022 Jun 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Carcinogenesis* , Gene Expression Regulation, Neoplastic*, Animals ; Humans ; Mice ; Proto-Oncogene Proteins c-bcl-6/metabolism

المؤلفون: Miller DSJ; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research London SW7 3RP UK., Voell SA; Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn D-53121 Bonn Germany c.steinebach@uni-bonn.de., Sosič I; Faculty of Pharmacy, University of Ljubljana SI-1000 Ljubljana Slovenia., Proj M; Faculty of Pharmacy, University of Ljubljana SI-1000 Ljubljana Slovenia., Rossanese OW; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research London SW7 3RP UK., Schnakenburg G; Institute of Inorganic Chemistry, University of Bonn D-53121 Bonn Germany., Gütschow M; Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn D-53121 Bonn Germany c.steinebach@uni-bonn.de., Collins I; Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research London SW7 3RP UK., Steinebach C; Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn D-53121 Bonn Germany c.steinebach@uni-bonn.de.

المصدر: RSC medicinal chemistry [RSC Med Chem] 2022 May 05; Vol. 13 (6), pp. 731-736. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem Subsets: PubMed not MEDLINE

المؤلفون: Miller DSJ; Developmental Signalling Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Bloxham RD; Developmental Signalling Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Jiang M; High Throughput Screening Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Gori I; Developmental Signalling Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Saunders RE; High Throughput Screening Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Das D; Developmental Signalling Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Chakravarty P; Bioinformatics and Biostatistics Facility, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Howell M; High Throughput Screening Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Hill CS; Developmental Signalling Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: caroline.hill@crick.ac.uk.

المصدر: Cell reports [Cell Rep] 2018 Nov 13; Vol. 25 (7), pp. 1841-1855.e5.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction*, Endosomal Sorting Complexes Required for Transport/*metabolism , Receptors, Transforming Growth Factor beta/*metabolism , Transforming Growth Factor beta/*metabolism, Activins/metabolism ; Animals ; Bone Morphogenetic Proteins/metabolism ; Cell Line ; Down-Regulation ; Epithelial-Mesenchymal Transition ; Genome, Human ; Humans ; Lysosomes/metabolism ; Mice ; Multivesicular Bodies/metabolism ; Neoplasms/pathology ; Phosphorylation ; Prognosis ; Protein Transport ; Proteolysis ; Smad2 Protein/metabolism ; Survival Analysis ; Ubiquitin-Protein Ligases/metabolism ; Up-Regulation